| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 9.1e-05 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.00041 | 1 |